Martin Sterba
Hradec Kralove, KR, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
sGC stimulator BAY 41-8543 improves survival and ventricular function in a rat model of doxorubicin-induced cardiomyopathy with nephrotic syndrome.
Journal: British journal of pharmacology
Published: October 30, 2025
Prenatal paroxetine dysregulates monoamine homeostasis and affects placental hemodynamics in the rat fetoplacental unit.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 30, 2025
Daunorubicin and its hydroxy metabolite in cardiomyocytes: insights into cellular kinetics, toxicity, DNA damage, and dexrazoxane-induced cardioprotection.
Journal: Archives of toxicology
Published: February 27, 2025
Topobexin targets the Topoisomerase II ATPase domain for beta isoform-selective inhibition and anthracycline cardioprotection.
Journal: Nature communications
Published: October 28, 2024
Impact of intraamniotic inflammation on tryptophan metabolism in the placenta-fetal brain axis in rats.
Journal: Reproduction (Cambridge, England)
Published: October 06, 2024
Volumetric absorptive microsampling meets electromembrane extraction for the first time: Case example of doxorubicin and its metabolite in whole blood samples.
Journal: Analytica chimica acta
Published: August 15, 2024
Characterization of a new model of chemotherapy-induced heart failure with reduced ejection fraction and nephrotic syndrome in Ren-2 transgenic rats.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: April 16, 2024
Exploring the effects of topoisomerase II inhibitor XK469 on anthracycline cardiotoxicity and DNA damage.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: January 30, 2024
Cardiac miRNA expression during the development of chronic anthracycline-induced cardiomyopathy using an experimental rabbit model.
Journal: Frontiers in pharmacology
Published: September 22, 2023
Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity.
Journal: Scientific reports
Published: February 22, 2023
Development of a Rat Model of Intra-Amniotic Inflammation via Ultrasound-Guided Administration of a Triggering Agent in the Gestational Sac to Enable Analysis of Individual Amniotic Fluid Samples.
Journal: Frontiers in pharmacology
Published: February 07, 2022
Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation.
Journal: Circulation. Heart failure
Published: September 23, 2021
Last Updated: 09/26/2026